RSI applies behavioral interpretation to fine-tune risk messages, ensuring they align with how different audiences process uncertainty, trust sources, and act under stress. RSI analysts incorporate framing effects, heuristics, and motivational cues to improve communication outcomes. The firm uses this method to enhance clarity, reduce misinterpretation, and support informed decision-making across sectors.

As a Risk Management Expert at RSI, John Lark brings a wealth of practical and policy-level experience to support strategic risk frameworks, enterprise-level risk reviews, and board advisory services. He contributes to RSI projects that require deep knowledge of international standards (especially ISO 31000) and risk integration into organizational governance and operations. His advisory scope spans both public and private sector clients, often at the interface of policy, compliance, and strategic foresight.

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties. The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas…

RSI designs and conducts M&E frameworks tailored to regulatory programs, emergency plans, or public engagement efforts. It defines meaningful indicators, collects robust data, and synthesizes findings for stakeholders. RSI emphasizes learning-oriented evaluation, helping clients improve programs while demonstrating value and performance.

There is no excerpt because this is a protected post.

Dr. Emma Hartnett is Vice-President, Risk Modelling and Simulation at Risk Sciences International (RSI), where she has been a foundational member since its inception in 2006. A globally recognized authority in quantitative risk assessment (QRA), she specializes in developing risk models and decision support tools for complex public health and safety challenges across biological, chemical, and environmental domains.

RSI incorporates communication risk registers into strategic planning for public-facing and high-stakes communication efforts. The firm identifies and evaluates risks to message credibility and reach, and develops mitigation strategies. RSI uses these tools to support adaptive messaging and institutional learning, especially in polarized or evolving risk contexts.

RSI prioritizes assumption transparency in all its modeling efforts. Whether developing toxicological, exposure, or economic risk models, RSI documents decisions, default values, and rationale using structured templates. This transparency supports external review, regulatory submission, and stakeholder confidence. It also facilitates iterative improvement and reuse of models in evolving contexts.

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments related to environmental contaminants and consumer products. His practice group supports government agencies, regulatory bodies, and international partners in making science-informed decisions that safeguard public health.

Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of myopericarditis – an inflammatory condition of the heart muscle – following mRNA COVID19 vaccination, with the highest risks seen in young males following a second vaccine dose.  Similar findings have…